Home › Acute Myeloid Leukemia › NCT01890486

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

The Prospective Collection, Storage and Reporting of Data on Patients

Who can join

Ages 18 to 120 · All sexes

Inclusion Criteria:

Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Exclusion Criteria:

Participation in any other treatment research protocol

About the study

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.

Sponsor: Wake Forest University Health Sciences · Participants: 2,000 · Started: May 21, 2001

Contact the study team

Official record on ClinicalTrials.gov — NCT01890486

Locations in the U.S.

Conditions

• Acute Myeloid Leukemia
• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Non-Hodgkin Lymphoma
• Hodgkin Lymphoma
• Multiple Myeloma
• Germ Cell and Embryonal Cancer
• Myelodysplastic Syndromes
• Chronic Lymphocytic Leukemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.